The tumor rejection effect of protein components from medicinal fungus

Biomedicine and Preventive Nutrition

Volumn 1, Issue 4, 2011, Pages 245-254

  Liang, Yi ^a,b   Chen, Yijie ^a   Liu, Honghong ^a   Luan, Rong ^a   Che, Tao ^a   Jiang, Shuai ^a   Xie, Dongyang ^c   Sun, Hui ^a  

^a WUHAN UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

Author keywords

Antitumor; Medicinal fungus; Mushroom; Protein

Indexed keywords

AGROCYBE AEGERITA EXTRACT; ANTINEOPLASTIC AGENT; CORDYCEPS MILITARIS EXTRACT; CYTOTOXIC AGENT; FUNGAL EXTRACT; GANODERMA LUCIDUM EXTRACT; LENTINULA EDODES EXTRACT; MESSENGER RNA; PLANT EXTRACT; UNCLASSIFIED DRUG;

AGROCYBE AEGERITA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CELL PROLIFERATION; CONTROLLED STUDY; CORDYCEPS; DRUG CYTOTOXICITY; DRUG DETERMINATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LIFE EXTENSION; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SPLEEN CELL; TUMOR REJECTION; TUMOR VOLUME;

EID: 83655191636     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2011.06.006     Document Type: Article

References (37)

1. Borchers A.T., Keen C.L., Gershwin M.E. Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) 2004, 229(5):393-406.
2. Borchers A.T., Stern J.S., Hackman R.M., Keen C.L., Gershwin M.E. Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 1999, 221(4):281-293.
3. Wasser S.P., Didukh Maryna Y., Nevo E. Antitumor and immunomodulatory activities of medicinal mushroom polysaccharides and polysaccharide-protein complexes in animals and humans (review). Mycologia balcanica 2005, 2:221-250.
4. Wasser S.P., Weis A.L. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 1999, 19(1):65-96.
5. Zaidman B.Z., Yassin M., Mahajna J., Wasser S.P. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 2005, 67(4):453-468.
6. Monro J.A. Treatment of cancer with mushroom products. Arch Environ Health 2003, 58(8):533-537.
7. Wasser S.P., Didukh Maryna Y., Nevo E. Dietary supplements from culinary-medicinal mushrooms: a variety of regulations and safety concerns for the 21st century. Int J Med Mushrooms 2004, 6:231-248.
8. Johnston N. Medicinal mushroom cuts off prostate cancer cells' blood supply. Drug Discov Today 2005, 10(23-24):1584.
9. Sullivan R., Smith J.E., Rowan N.J. Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med 2006, 49(2):159-170.
10. Ho J.C., Konerding M.A., Gaumann A., Groth M., Liu W.K. Fungal polysaccharopeptide inhibits tumor angiogenesis and tumor growth in mice. Life Sci 2004, 75(11):1343-1356.
11. Ooi V.E.C., Liu F. A review of pharmacological activities of mushroom polysaccharides. Int J Med Mushrooms 1999, 1:195-206.
12. Wasser S.P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 2002, 60(3):7.
13. Ross G.D., Vetvicka V., Yan J., Xia Y., Vetvickova J. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology 1999, 42(1-3):61-74.
14. Xia Y., Vetvicka V., Yan J., Hanikyrova M., Mayadas T., Ross G.D. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J Immunol 1999, 162(4):2281-2290.
15. Breene W.M. Nutritional and medicinal value of specialty mushrooms. J Food Prot 1990, 53(10):883-894.
16. Kawagishi H., Nomura A., Mizuno T., Kimura A., Chiba S. Isolation and characterization of a lectin from Grifola frondosa fruiting bodies. Biochim Biophys Acta 1990, 1034(3):247-252.
17. Yu L., Fernig D.G., Smith J.A., Milton J.D., Rhodes J.M. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin. Cancer Res 1993, 53(19):4627-4632.
18. Liua W., Ho J.C., Ng T. Suppression of cell cycle progression by a fungal lectin: activation of cyclin-dependent kinase inhibitors. Biochem Pharmacol 2001, 61(1):33-37.
19. Koyama Y., Katsuno Y., Miyoshi N., Hayakawa S., Mita T., Muto H., et al. Apoptosis induction by lectin isolated from the mushroom Boletopsis leucomelas in U937 cells. Biosci Biotechnol Biochem 2002, 66(4):784-789.
20. Zhao C., Sun H., Tong X., Qi Y. An antitumour lectin from the edible mushroom Agrocybe aegerita. Biochem J 2003, 374(Pt 2):321-327.
21. Pohleven J., Obermajer N., Sabotic J., Anzlovar S., Sepcic K., Kos J., et al. Purification, characterization and cloning of a ricin B-like lectin from mushroom clitocybe nebularis with antiproliferative activity against human leukemic T cells. Biochim Biophys Acta 2009, 1790(3):173-181.
22. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956, 28:350-356.
23. Strahler J.R., Kuick R., Hanash S.M. Two-dimensional polyacrylamide gel electrophoresis of proteins. Protein structure: a practical approach 1989, IRL Press, Ltd, Oxford, p. 65-92. T.E. Creighton (Ed.).
24. Leon I.R., Neves-Ferreira A.G., Valente R.H., Mota E.M., Lenzi H.L., Perales J. Improved protein identification efficiency by mass spectrometry using N-terminal chemical derivatization of peptides from Angiostrongylus costaricensis, a nematode with unknown genome. J Mass Spectrom 2007, 42(6):781-792.
25. Igawa T., Lin F.F., Lee M.S., Karan D., Batra S.K., Lin M.F. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. Prostate 2002, 50(4):222-235.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
27. Yang N., Tong X., Xiang Y., Zhang Y., Liang Y., Sun H., et al. Molecular character of the recombinant antitumor lectin from the edible mushroom Agrocybe aegerita. J Biochem 2005, 138(2):145-150.
28. Sun Y., Liu J. Purification, structure and immunobiological activity of a water-soluble polysaccharide from the fruiting body of Pleurotus ostreatus. Bioresour Technol 2009, 100(2):983-986.
29. Torchilin V.P., Lukyanov A.N. Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today 2003, 8(6):259-266.
30. Bhutia S.K., Maiti T.K. Targeting tumors with peptides from natural sources. Trends Biotechnol 2008, 26(4):210-217.
31. Jyllian N.K. Analyzing protein drugs. Chem Eng News 2009, 87:20-23.
32. Asselin B.L. The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia. Adv Exp Med Biol 1999, 457:621-629.
33. Drucker D.J., Buse J.B., Taylor K., Kendall D.M., Trautmann M., Zhuang D., et al. Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet 2008, 372(9645):1240-1250.
34. Ng T.B. Peptides and proteins from fungi. Peptides 2004, 25(6):1055-1073.
35. Ooi V.E., Liu F. Immunomodulation and anticancer activity of polysaccharide-protein complexes. Curr Med Chem 2000, 7(7):715-729.
36. Crittenden M.R., Thanarajasingam U., Vile R.G., Gough M.J. Intratumoral immunotherapy: using the tumour against itself. Immunology 2005, 114(1):11-22.
37. Eggermont A.M., de Wilt J.H., ten Hagen T.L. Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol 2003, 4(7):429-437.